Deficiency of myeloid TLR4 blunts the immunogenic activity of macrophages and suppresses T cell-mediated experimental anti-GBM GN by shifting the Th1/Th17 towards the T reg immune responses. Here, TLR4 is linked to ganglioneuroma.